Two-year Outcomes after Intravitreal Anti-vascular Endothelial Growth Factor Therapy for Polypoidal Choroidal Vasculopathy Patients with Good Initial Visual Acuity
Abstract:Purpose:To investigate 2-year treatment outcomes of anti-vascular endothelial growth factor (VEGF) therapy in eyes with polypoidal choroidal vasculopathy (PCV) with good baseline visual acuity. Methods: This retrospective, observational study included 21 eyes (10 eyes with a subfoveal polyp, 11 eyes with an extrafoveal polyp) of 21 subjects diagnosed with PCV. All eyes had a baseline best-corrected visual acuity (BCVA) of 20/25 or better and were administered an initial treatment of three intravitrial anti-VEG… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.